High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$185M
$185,313,015
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| ROIV |
Roivant Sciences Ltd.
|
President
Other
|
2026-02-23 | $2,261,452Large | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
President
10b5-1 Sell
|
2026-02-23 | $16,159,099MEGA | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
President
Other
|
2026-02-20 | $3,898,548Large | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
President
10b5-1 Sell
|
2026-02-20 | $27,492,362MEGA | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
President
Other
|
2026-02-19 | $5,390,000Whale | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
President
10b5-1 Sell
|
2026-02-19 | $38,388,000MEGA | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Gold Daniel Allen
• Director
Discretionary Sell
2026-02-13
$9,956,768Whalex2
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2026-02-13 | $9,956,768Whalex2 | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
MANCHESTER KEITH S
• Director
Discretionary Sell
2026-02-13
$9,956,768Whalex2
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2026-02-13 | $9,956,768Whalex2 | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
QVT Financial LP
• Other
Discretionary Sell
2026-02-13
$9,956,768Whalex2
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Other
Discretionary Sell
|
2026-02-13 | $9,956,768Whalex2 | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2026-02-13 | $770,000 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -10.8%
|
2026-02-13 | $5,298,000Whale | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Gold Daniel Allen
• Director
Discretionary Sell
2026-02-12
$11,367,000MEGAx2
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2026-02-12 | $11,367,000MEGAx2 | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
MANCHESTER KEITH S
• Director
Discretionary Sell
2026-02-12
$11,367,000MEGAx2
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2026-02-12 | $11,367,000MEGAx2 | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
QVT Financial LP
• Other
Discretionary Sell
2026-02-12
$11,367,000MEGAx2
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Other
Discretionary Sell
|
2026-02-12 | $11,367,000MEGAx2 | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Gold Daniel Allen
• Director
Discretionary Sell
2026-02-11
$11,334,750MEGA
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2026-02-11 | $11,334,750MEGA | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
MANCHESTER KEITH S
• Director
Discretionary Sell
2026-02-11
$11,334,750MEGA
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2026-02-11 | $11,334,750MEGA | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
Other
Discretionary Sell
|
2026-02-11 | $11,334,750MEGA | S | Form 4 |